Efficacy and safety of immune checkpoint inhibitors (ICI) for the treatment of metastatic penile squamous cell carcinoma (mPSCC)

Authors

Tiewei Cheng
Timothy J. Schieber
Anna Clennon, Advocate Health - MidwestFollow
Katie Bertken
Sunny Shengyuan Cai
Elizabeth Marie Wulff-Burchfield
Saqib Abbasi
Rahul Atul Parikh
Haoran Li

Recommended Citation

Cheng T, Schieber TJ, Clennon A, et al. Efficacy and safety of immune checkpoint inhibitors (ICI) for the treatment of metastatic penile squamous cell carcinoma (mPSCC). Journal of Clinical Oncology. 2025;43(5_suppl):4-4. doi:10.1200/JCO.2025.43.5_suppl.4

Affiliations

Aurora St. Luke's Medical Center

Document Type

Abstract